Form 4: Orchestra BioMed Executive William Reed Little Acquires 4,000 Shares
SEC Form 4
William Reed Little, an executive at Orchestra BioMed Holdings, Inc., purchased 4,000 shares of common stock at $7 per share on May 30, 2024.
Summary
- On May 30, 2024, William Reed Little, Executive Vice President, Corporate Development & Strategy at Orchestra BioMed Holdings, Inc., acquired 4,000 shares of common stock.
- The purchase price was $7 per share.
- Following the transaction, Little directly owns 307,859 shares, which includes 303,859 restricted stock units (RSUs).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of an executive stock purchase. While insider buying can be seen as positive, it's a small transaction relative to the executive's existing holdings.
Positives
- An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive sentiment and potential alignment of interests.
Stakeholder Impact
- The transaction provides shareholders with insight into the actions of company executives.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of stock purchase transaction |
| 06/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.